Atlas Trials

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis

Clinical trial NCT03526900 · COMPLETED

Trial details

NCT number
NCT03526900
Sponsor
Spanish Lung Cancer Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer Stage IV
Start date
2018-07-07
Primary completion
2022-03-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.